Search Results

Influence of Previous Therapy for Neutropenia Caused by Combination Therapy of Ramucirumab and Docetaxel.

• Authors : Ohno, Hiroyuki¹ (AUTHOR) ; Hayashi, Takahiro² (AUTHOR) ; Torii, Shota³ (AUTHOR)

• Source: Cancers. Jun2024, Vol. 16 Issue 11, p2076. 13p.

Record details

Real‐world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non‐small cell lung cancer.

• Authors : Kaneko, Ayami¹ (AUTHOR); Kobayashi, Nobuaki¹ (AUTHOR) ; Miura, Kenji² (AUTHOR)

• Source: Thoracic Cancer. May2024, Vol. 15 Issue 15, p1208-1217. 10p.

Record details

A multi-center cross-sectional study of Chinese Herbal Medicine-Drug adverse reactions using active surveillance in Singapore's Traditional Chinese Medicine clinics.

• Authors : Ng, Chester Yan Jie¹ (AUTHOR); Zhao, Yan¹ (AUTHOR); Wang, Ning² (AUTHOR)

• Source: Chinese Medicine. 3/7/2024, Vol. 19 Issue 1, p1-20. 20p.

Record details

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.

• Authors : Juan Fita, María José¹ (AUTHOR) ; Anido Herranz, Urbano² (AUTHOR) ; Mendez-Vidal, María José³ (AUTHOR)

• Source: Cancers. Nov2023, Vol. 15 Issue 21, p5223. 12p.

Record details

Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.

• Authors : Angelopoulos, Nicholas^1,2 ; Paparodis, Rodis D.^3,4; Androulakis, Ioannis^1,5

Subjects: *THERAPEUTIC use of ubiquinones; *RESEARCH; *CARDIOVASCULAR diseases risk factors

• Source: Nutrients. Jun2023, Vol. 15 Issue 12, p2682. 12p.

Record details

Association between Body Composition and Peripheral Neurotoxicity in Cancer Patients from North China Taking Nab-Paclitaxel.

• Authors : Guo, Jiayuan¹; Zhao, Juan²; Gu, Ming²

Subjects: *BODY composition; *NEUROTOXICOLOGY; *RESEARCHCHINA

• Source: Nutrition & Cancer. 2023, Vol. 75 Issue 3, p805-814. 10p. 1 Color Photograph, 1 Diagram, 6 Charts, 1 Graph.

Record details

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.

• Authors : Gordon, Erlinda Maria^1,2 (AUTHOR) ; Chawla, Sant P.¹ (AUTHOR); Tellez, Walter Andree¹ (AUTHOR)

• Source: Cancers. Feb2023, Vol. 15 Issue 3, p906. 12p.

Record details

Effect of a Dietary Supplement Combining Bioactive Peptides and Magnesium on Adjustment Disorder with Anxiety: A Clinical Trial in General Practice.

• Authors : Oddoux, Sarah¹ ; Violette, Paul¹ ; Cornet, Jeanne²

Subjects: *RESEARCH; *DIETARY bioactive peptides; *COMBINATION drug therapy

• Source: Nutrients. Jun2022, Vol. 14 Issue 12, p2425-N.PAG. 16p.

Record details

STAT3 Expression and Its Correlation with PD-L1 Expression in Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma at Dr. Saiful Anwar Regional Public Hospital in Malang, Indonesian Population.

• Authors : Hambalie, Ailen Oktaviana^1,2 (AUTHOR); Norahmawati, Eviana^1,2 (AUTHOR); Endharti, Agustina Tri³ (AUTHOR)

• Source: Advances in Hematology. 5/23/2024, Vol. 2024, p1-8. 8p.

Record details

The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study

• Authors : Nurul Choudhury; Ashley Jaggi; Rob van Maanen

Subjects: Male; chemistry.chemical_compound; 5-alpha Reductase Inhibitors

• Source: BMC Urology, Vol 21, Iss 1, Pp 1-18 (2021)BMC Urology

Record details